Glaucoma is one of the three leading causes of blindness in Germany and worldwide. This neurodegenerative disease progressively damages the retinal nerve fibres, leading to irreversible vision loss.

Glaucoma is often called the "silent thief of sight" because it usually causes no symptoms until permanent vision loss has ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Thank you for signing up! Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, ...

Using pilocarpine eye drops following Kahook Dual Blade (KDB) goniotomy surgery may improve clinical outcomes for patients with glaucoma and reduce the need for future medications, according to new ...

Glaucoma impacts the vision of more than 3 million Americans, increasing the pressure in the eye, damaging the optic nerve and, if left untreated, causing permanent damage and vision loss. Until now, ...

The CDC reports that over three million Americans have glaucoma. The number may reach 6.3 million by 2050 as the aging population grows. Glaucoma is affecting so many lives, so it’s important to know ...

Please provide your email address to receive an email when new articles are posted on . Interventional procedures with eye drops as an adjunct are slowly becoming the foundational therapy for glaucoma ...

After 28 days of treatment, BL1107 did not meet its main goal of improving visual field scores in a study.

CHICAGO -- Upfront laser trabeculoplasty significantly slowed glaucoma progression and vision loss as compared with eye drops, long-term follow-up from a large randomized trial showed. After 6 years ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Dry eye prevalence based on Ocular Surface Disease Index ...

Bausch + Lomb said on Thursday its glaucoma eye drop had missed ​the main goal in a mid-stage ‌trial of replicating visual function improvements observed in a smaller study.